INFECTION DURING PREGNANCY IS LIFE THREATENING FOR BABIES

464,000 moms pass infection

to 60,000 babies every year

Causing fever

in the mom

and lung disease,

developmental delay, & death in the newborn

A $750M market opportunity addressing a $15B problem in the U.S. alone!

 

A $3B market opportunity addressing a $56B problem in the developed world!

Healthier moms & Babies, Fewer Complications

RAPID DIAGNOSIS

In Pregnancy, Labor

& in the Newborn ICU

EARLY TREATMENT

Penicillin for GBS

Azythromycin for Ureaplasma

Cephalosporin/Amnioglyoside for E coli

HEALTHIER PATIENTS

The right diagnosis

At the right time

For the right treatment

The right solution at the right time

Current methods to diagnose infection are not adequate.

Vax-Immune has developed a method to rapidly diagnose infection enabling physicians to prescribe the right treatment at the right time.

Vax-Immune has ENABLED rapid diagnosIS of these pathogens

during pregnancy, labor and in the Newborn ICU.

PRINCIPALS

ADVISORS

Adam Deltz, Advisor

Founder & CTO of

Ortho Kinematics

Matthew Duffy, Advisor

25 years in healthcare

marketing & sales

Gerald Fischer, MD, Advisor

Internationally recognized in

pediatric infectious diseases

Ted Holland, Advisor

18 years of biopharmaceutical

marketing experience

Jon Polanich, Advisor

Novo Nordisk, AstraZeneca,

Endo Pharmaceutics & IMS Health

Caroline Popper, MD, Advisor

President of BCM Technologies

(BCMT)

Irwin Scher, MD, Advisor

Chief Executive Officer of

Biosynexus Incorporated

Leonard E. Weisman, MD, President and Chief Technology Officer

 

Dr. Weisman is a seasoned inventor with formal development experience (Medimmune, Inc.- sold for $15.6 B in 2007, and Biosynexus, Inc. secured $120 M in venture capital). Practicing neonatal medicine and research for over 35 years, Professor of Pediatrics at Baylor College of Medicine with 260 academic publications and $15 M in extramural research funding. BS in Engineering, USMA West Point, M.D. Baylor College of Medicine. Dr. Weisman is a retired U. S. Army colonel.

Bhairavi Parikh, PhD, Chief Product Development Officer

 

Bhairavi is an experienced entrepreneur with extensive experience in medical diagnostics and women and children’s health.  She has founded 3 companies including Apieron Biosystems, CellScape Corporation and CrestaBio, securing over $75MM in financing.  She has a PhD in Biomedical Engineering from Worcester Polytechnic Institute and University Massachusetts Medical School.

Joaquin Altenberg, MBA, BSEE,  Chief Financial Officer

 

Joaquin is a seasoned entrepreneur in biotechnology, technology and energy sectors and has grown companies in roles as CEO, CFO and business development. He has secured over $3.0 B in financing, and has served in investment or advisory positions with Salomon Smith Barney, Morgan Stanley, Citigroup, Lazard, and Vert Investment Group. University of Texas at Austin, B.S. in Biomedical and Computer Engineering and an MBA from Harvard Business School.

$3 BILLION: MARKET POTENTIAL

GLOBAL MISSION

RAPID DIAGNOSIS OF INFECTIOUS DISEASE IN THE DEVELOPED WORLD

NEWS

Harvard Business School Alumni

New Venture Competition

 

Regional Winner (Texas)

& International Finalist

Goradia Innovation

 

3rd Place Award

Texas Emerging Technology Fund

 

Gulf Coast and Dallas Regional Finalist

National Council of Entrepreneurial Tech Transfer

 

Present and Attend

Conference & Showcase

Required

Required

Required

Submitting Form...

The server encountered an error.

Form received.

Disclaimer / Privacy Policy

 

All contents of this site including but not limited to all original text, graphics, logos, images, data, buttons, icons and the like were developed at considerable expense to and are the exclusive property of Vax-Immune, LLC.  By accessing and/or browsing this Web site you hereby acknowledge that the contents are encompassed by United States and other International laws, regulations and statutes for the protection of intellectual property and other business interests including but not limited to those regarding the protection of proprietary information, patents, trademarks, service marks, trade names, trade secrets, trade dress, and copyright.

Vax-Immune | ©2016